메뉴 건너뛰기




Volumn 189, Issue 6, 2012, Pages 3198-3208

Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; HEMOGLOBIN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

EID: 84866152555     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200602     Document Type: Article
Times cited : (78)

References (48)
  • 1
    • 53249123632 scopus 로고    scopus 로고
    • International Agency for Research on Cancer, and World Health Organization International Agency for Research on Cancer, Lyon, France
    • Swerdlow, S., International Agency for Research on Cancer, and World Health Organization. 2008. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon, France.
    • (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
    • Swerdlow, S.1
  • 4
    • 53149113768 scopus 로고    scopus 로고
    • Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
    • Kantarjian, H., S. O'Brien, F. Ravandi, J. Cortes, J. Shan, J. M. Bennett, A. List, P. Fenaux, G. Sanz, J. P. Issa, et al. 2008. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 113: 1351-1361.
    • (2008) Cancer , vol.113 , pp. 1351-1361
    • Kantarjian, H.1    O'Brien, S.2    Ravandi, F.3    Cortes, J.4    Shan, J.5    Bennett, J.M.6    List, A.7    Fenaux, P.8    Sanz, G.9    Issa, J.P.10
  • 5
    • 53549108334 scopus 로고    scopus 로고
    • International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: Impact of cytopenias on clinical outcomes in myelodysplastic syndromes
    • Kao, J. M., A. McMillan, and P. L. Greenberg. 2008. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes. Am. J. Hematol. 83: 765-770.
    • (2008) Am. J. Hematol. , vol.83 , pp. 765-770
    • Kao, J.M.1    McMillan, A.2    Greenberg, P.L.3
  • 7
    • 7344223859 scopus 로고    scopus 로고
    • Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor V(β) profiles
    • DOI 10.1046/j.1365-2141.1998.00920.x
    • Molldrem, J. J., Y. Z. Jiang, M. Stetler-Stevenson, D. Mavroudis, N. Hensel, and A. J. Barrett. 1998. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles. Br. J. Haematol. 102: 1314-1322. (Pubitemid 28435218)
    • (1998) British Journal of Haematology , vol.102 , Issue.5 , pp. 1314-1322
    • Molldrem, J.J.1    Jiang, Y.Z.2    Stetler-Stevenson, M.3    Mavroudis, D.4    Hensel, N.5    Barrett, A.J.6
  • 9
    • 23044473715 scopus 로고    scopus 로고
    • Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome
    • DOI 10.1182/blood-2004-05-2017
    • Sloand, E. M., L. Mainwaring, M. Fuhrer, S. Ramkissoon, A. M. Risitano, K. Keyvanafar, J. Lu, A. Basu, A. J. Barrett, and N. S. Young. 2005. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood 106: 841-851. (Pubitemid 41076423)
    • (2005) Blood , vol.106 , Issue.3 , pp. 841-851
    • Sloand, E.M.1    Mainwaring, L.2    Fuhrer, M.3    Ramkissoon, S.4    Risitano, A.M.5    Keyvanafar, K.6    Lu, J.7    Basu, A.8    Barrett, A.J.9    Young, N.S.10
  • 11
    • 0037272767 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
    • DOI 10.1046/j.1365-2141.2003.03907.x
    • Bowen, D., D. Culligan, S. Jowitt, S. Kelsey, G. Mufti, D. Oscier, and J. Parker; UK MDS Guidelines Group. 2003. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br. J. Haematol. 120: 187-200. (Pubitemid 36194166)
    • (2003) British Journal of Haematology , vol.120 , Issue.2 , pp. 187-200
    • Bowen, D.1    Culligan, D.2    Jowitt, S.3    Kelsey, S.4    Mufti, G.5    Oscier, D.6    Parker, J.7
  • 12
    • 0033168037 scopus 로고    scopus 로고
    • Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody
    • Onizuka, S., I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita, and E. Nakayama. 1999. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res. 59: 3128-3133. (Pubitemid 29316012)
    • (1999) Cancer Research , vol.59 , Issue.13 , pp. 3128-3133
    • Onizuka, S.1    Tawara, I.2    Shimizu, J.3    Sakaguchi, S.4    Fujita, T.5    Nakayama, E.6
  • 15
    • 77952754636 scopus 로고    scopus 로고
    • Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO
    • Booth, N. J., A. J. McQuaid, T. Sobande, S. Kissane, E. Agius, S. E. Jackson, M. Salmon, F. Falciani, K. Yong, M. H. Rustin, et al. 2010. Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO. J. Immunol. 184: 4317-4326.
    • (2010) J. Immunol. , vol.184 , pp. 4317-4326
    • Booth, N.J.1    McQuaid, A.J.2    Sobande, T.3    Kissane, S.4    Agius, E.5    Jackson, S.E.6    Salmon, M.7    Falciani, F.8    Yong, K.9    Rustin, M.H.10
  • 16
    • 24944583626 scopus 로고    scopus 로고
    • Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics
    • DOI 10.1038/ni1240, PII N1240
    • Bromley, S. K., S. Y. Thomas, and A. D. Luster. 2005. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol. 6: 895-901. (Pubitemid 43090444)
    • (2005) Nature Immunology , vol.6 , Issue.9 , pp. 895-901
    • Bromley, S.K.1    Thomas, S.Y.2    Luster, A.D.3
  • 18
    • 0035937587 scopus 로고    scopus 로고
    • Preferential localization of effector memory cells in nonlymphoid tissue
    • DOI 10.1126/science.1058867
    • Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrancois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417. (Pubitemid 32231804)
    • (2001) Science , vol.291 , Issue.5512 , pp. 2413-2417
    • Masopust, D.1    Vezys, V.2    Marzo, A.L.3    Lefrancois, L.4
  • 19
    • 0033554726 scopus 로고    scopus 로고
    • Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
    • Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
    • (1999) Nature , vol.401 , pp. 708-712
    • Sallusto, F.1    Lenig, D.2    Förster, R.3    Lipp, M.4    Lanzavecchia, A.5
  • 22
    • 9244244736 scopus 로고    scopus 로고
    • Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells
    • DOI 10.1084/jem.20041022
    • van Santen, H. M., C. Benoist, and D. Mathis. 2004. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200: 1221-1230. (Pubitemid 39552564)
    • (2004) Journal of Experimental Medicine , vol.200 , Issue.10 , pp. 1221-1230
    • Van Santen, H.-M.1    Benoist, C.2    Mathis, D.3
  • 25
    • 0141688283 scopus 로고    scopus 로고
    • Adoptive-cell-transfer therapy for the treatment of patients with cancer
    • Dudley, M. E., and S. A. Rosenberg. 2003. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat. Rev. Cancer 3: 666-675. (Pubitemid 37328821)
    • (2003) Nature Reviews Cancer , vol.3 , Issue.9 , pp. 666-675
    • Dudley, M.E.1    Rosenberg, S.A.2
  • 26
  • 27
    • 0000834072 scopus 로고
    • Immunology of Experimental Tumors
    • Old, L. J., and E. A. Boyse. 1964. Immunology of Experimental Tumors. Annu. Rev. Med. 15: 167-186.
    • (1964) Annu. Rev. Med. , vol.15 , pp. 167-186
    • Old, L.J.1    Boyse, E.A.2
  • 28
    • 33846485153 scopus 로고    scopus 로고
    • Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
    • DOI 10.1038/ni1428, PII NI1428
    • Kim, J. M., J. P. Rasmussen, and A. Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8: 191-197. (Pubitemid 46152650)
    • (2007) Nature Immunology , vol.8 , Issue.2 , pp. 191-197
    • Kim, J.M.1    Rasmussen, J.P.2    Rudensky, A.Y.3
  • 29
    • 0036669298 scopus 로고    scopus 로고
    • CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice: Implications for the nonredundant function of IL-2
    • DOI 10.1016/S1074-7613(02)00367-9
    • Malek, T. R., A. Yu, V. Vincek, P. Scibelli, and L. Kong. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17: 167-178. (Pubitemid 35245959)
    • (2002) Immunity , vol.17 , Issue.2 , pp. 167-178
    • Malek, T.R.1    Yu, A.2    Vincek, V.3    Scibelli, P.4    Kong, L.5
  • 30
    • 0037364804 scopus 로고    scopus 로고
    • Natural versus adaptive regulatory T cells
    • DOI 10.1038/nri1032
    • Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257. (Pubitemid 37323210)
    • (2003) Nature Reviews Immunology , vol.3 , Issue.3 , pp. 253-257
    • Bluestone, J.A.1    Abbas, A.K.2
  • 32
    • 16844365788 scopus 로고    scopus 로고
    • + regulatory T cells in immunological tolerance to self and non-self
    • DOI 10.1038/ni1178
    • Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352. (Pubitemid 41716771)
    • (2005) Nature Immunology , vol.6 , Issue.4 , pp. 345-352
    • Sakaguchi, S.1
  • 33
    • 0035054606 scopus 로고    scopus 로고
    • Human CD4(+) CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro
    • Stephens, L. A., C. Mottet, D. Mason, and F. Powrie. 2001. Human CD4(+) CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31: 1247-1254.
    • (2001) Eur. J. Immunol. , vol.31 , pp. 1247-1254
    • Stephens, L.A.1    Mottet, C.2    Mason, D.3    Powrie, F.4
  • 37
    • 16844378685 scopus 로고    scopus 로고
    • Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma
    • DOI 10.1158/0008-5472.CAN-04-3232
    • Ormandy, L. A., T. Hillemann, H. Wedemeyer, M. P. Manns, T. F. Greten, and F. Korangy. 2005. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 65: 2457-2464. (Pubitemid 40490158)
    • (2005) Cancer Research , vol.65 , Issue.6 , pp. 2457-2464
    • Ormandy, L.1    Hillemann, T.2    Wedemeyer, H.3    Manns, M.P.4    Greten, T.F.5    Korangy, F.6
  • 38
    • 16244393380 scopus 로고    scopus 로고
    • Compromised lymphocytes infiltrate hepatocellular carcinoma: The role of T-regulatory cells
    • DOI 10.1002/hep.20644
    • Unitt, E., S. M. Rushbrook, A. Marshall, S. Davies, P. Gibbs, L. S. Morris, N. Coleman, and G. J. Alexander. 2005. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 41: 722-730. (Pubitemid 40462933)
    • (2005) Hepatology , vol.41 , Issue.4 , pp. 722-730
    • Unitt, E.1    Rushbrook, S.M.2    Marshall, A.3    Davies, S.4    Gibbs, P.5    Morris, L.S.6    Coleman, N.7    Alexander, G.J.M.8
  • 39
    • 3142737258 scopus 로고    scopus 로고
    • high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells
    • Viguier, M., F. Lemaître, O. Verola, M. S. Cho, G. Gorochov, L. Dubertret, H. Bachelez, P. Kourilsky, and L. Ferradini. 2004. Foxp3 expressing CD4+CD25 (high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J. Immunol. 173: 1444-1453. (Pubitemid 38924326)
    • (2004) Journal of Immunology , vol.173 , Issue.2 , pp. 1444-1453
    • Viguier, M.1    Lemaitre, F.2    Verola, O.3    Cho, M.-S.4    Gorochov, G.5    Dubertret, L.6    Bachelez, H.7    Kourilsky, P.8    Ferradini, L.9
  • 40
    • 1642497640 scopus 로고    scopus 로고
    • + Regulatory T Cells and Their Ligands: Implications for Immunotherapy
    • DOI 10.1016/S1074-7613(03)00359-5
    • Wang, H. Y., D. A. Lee, G. Peng, Z. Guo, Y. Li, Y. Kiniwa, E. M. Shevach, and R. F. Wang. 2004. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20: 107-118. (Pubitemid 38134298)
    • (2004) Immunity , vol.20 , Issue.1 , pp. 107-118
    • Wang, H.Y.1    Lee, D.A.2    Peng, G.3    Guo, Z.4    Li, Y.5    Kiniwa, Y.6    Shevach, E.M.7    Wang, R.-F.8
  • 41
    • 14044257258 scopus 로고    scopus 로고
    • + regulatory T cells
    • Wang, H. Y., G. Peng, Z. Guo, E. M. Shevach, and R. F. Wang. 2005. Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells. J. Immunol. 174: 2661-2670. (Pubitemid 40279680)
    • (2005) Journal of Immunology , vol.174 , Issue.5 , pp. 2661-2670
    • Wang, H.Y.1    Peng, G.2    Guo, Z.3    Shevach, E.M.4    Wang, R.-F.5
  • 42
    • 0035874949 scopus 로고    scopus 로고
    • + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
    • Woo, E. Y., C. S. Chu, T. J. Goletz, K. Schlienger, H. Yeh, G. Coukos, S. C. Rubin, L. R. Kaiser, and C. H. June. 2001. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 61: 4766-4772. (Pubitemid 32691889)
    • (2001) Cancer Research , vol.61 , Issue.12 , pp. 4766-4772
    • Woo, E.Y.1    Chu, C.S.2    Goletz, T.J.3    Schlienger, K.4    Yeh, H.5    Coukos, G.6    Rubin, S.C.7    Kaiser, L.R.8    June, C.H.9
  • 43
    • 33646422454 scopus 로고    scopus 로고
    • Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
    • Yang, Z. Z., A. J. Novak, M. J. Stenson, T. E. Witzig, and S. M. Ansell. 2006. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107: 3639-3646.
    • (2006) Blood , vol.107 , pp. 3639-3646
    • Yang, Z.Z.1    Novak, A.J.2    Stenson, M.J.3    Witzig, T.E.4    Ansell, S.M.5
  • 48
    • 45149093744 scopus 로고    scopus 로고
    • Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy
    • Sloand, E. M., C. O. Wu, P. Greenberg, N. Young, and J. Barrett. 2008. Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy. J. Clin. Oncol. 26: 2505-2511.
    • (2008) J. Clin. Oncol. , vol.26 , pp. 2505-2511
    • Sloand, E.M.1    Wu, C.O.2    Greenberg, P.3    Young, N.4    Barrett, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.